A universal vaccine against leptospirosis: Are we going in the right direction?

Frontiers in Immunology

Volumn 8, Issue MAR, 2017, Pages

  Grassmann, André Alex ^a   Souza, Jéssica Dias ^a   McBride, Alan John Alexander ^a,b  

^a FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Animal model; Genome mining; Leptospira; Recombinant vaccine; Reverse vaccinology; Subunit vaccine; Vaccine candidate; Vaccine discovery

Indexed keywords

BACTERIN; CARBON NANOTUBE; DNA VACCINE; FLAGELLIN; LEPTOSPIROSIS VACCINE; LIPOPOLYSACCHARIDE; LIPOSOME; MONOCLONAL ANTIBODY; OUTER MEMBRANE PROTEIN LIPL32; RECOMBINANT VACCINE; XANTHAN;

ARTICLE; AUTOIMMUNE DISEASE IMMUNOFLUORESCENCE ASSAY; BACTERIAL COLONIZATION; BACTERIAL OUTER MEMBRANE; BACTERICIDAL ACTIVITY; BACTERIUM MUTANT; BIOINFORMATICS; BLOOD CLOTTING; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CROSS PROTECTION; GENE INACTIVATION; HUMAN; IMMUNE RESPONSE; LEPTOSPIRA; LEPTOSPIRA BORGPETERSENII; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; NEISSERIA MENINGITIDIS; NONHUMAN; PATHOGENICITY; PHAGOCYTOSIS; SEPTIC SHOCK; SEQUENCE ANALYSIS; STAPHYLOCOCCUS AUREUS; UPREGULATION;

EID: 85017238775     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00256     Document Type: Article

References (99)

1. Adler B. History of leptospirosis and Leptospira. Curr Top Microbiol Immunol (2015) 387:1-9. doi:10.1007/978-3-662-45059-8_1
2. Vinetz JM, Glass GE, Flexner CE, Mueller P, Kaslow DC. Sporadic urban leptospirosis. Ann Intern Med (1996) 125(10):794-8. doi:10.7326/0003-4819-125-10-199611150-00002
3. McBride AJ, Athanazio DA, Reis MG, Ko AI. Leptospirosis. Curr Opin Infect Dis (2005) 18(5):376-86. doi:10.1097/01.qco.0000178824.05715.2c
4. WHO. Leptospirosis worldwide, 1999. Wkly Epidemiol Rec (1999) 74(29):237-42.
5. Costa F, Hagan JE, Calcagno J, Kane M, Torgerson P, Martinez-Silveira MS, et al. Global morbidity and mortality of leptospirosis: a systematic review. PLoS Negl Trop Dis (2015) 9(9):e0003898. doi:10.1371/journal.pntd.0003898
6. Croda J, Neto AN, Brasil RA, Pagliari C, Nicodemo AC, Duarte MI. Leptospirosis pulmonary haemorrhage syndrome is associated with linear deposition of immunoglobulin and complement on the alveolar surface. Clin Microbiol Infect (2010) 16(6):593-9. doi:10.1111/j.1469-0691.2009.02916.x
7. Gouveia EL, Metcalfe J, de Carvalho AL, Aires TS, Villasboas-Bisneto JC, Queirroz A, et al. Leptospirosis-associated severe pulmonary hemorrhagic syndrome, Salvador, Brazil. Emerg Infect Dis (2008) 14(3):505-8. doi:10.3201/eid1403.071064
8. Haake DA, Levett PN. Leptospirosis in humans. Curr Top Microbiol Immunol (2015) 387:65-97. doi:10.1007/978-3-662-45059-8_5
9. Ellis WA. Animal leptospirosis. Curr Top Microbiol Immunol (2015) 387:99-137. doi:10.1007/978-3-662-45059-8_6
10. Adler B. Vaccines against leptospirosis. Curr Top Microbiol Immunol (2015) 387:251-72. doi:10.1007/978-3-662-45059-8_10
11. Murray GL. The molecular basis of leptospiral pathogenesis. Curr Top Microbiol Immunol (2015) 387:139-85. doi:10.1007/978-3-662-45059-8_7
12. Levett PN. Systematics of leptospiraceae. Curr Top Microbiol Immunol (2015) 387:11-20. doi:10.1007/978-3-662-45059-8_2
13. Sridhar S. Heterosubtypic T-cell immunity to influenza in humans: challenges for universal T-cell influenza vaccines. Front Immunol (2016) 7:195. doi:10.3389/fimmu.2016.00195
14. Cho A, Wrammert J. Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine. Curr Opin Virol (2016) 17:110-5. doi:10.1016/j.coviro.2016.03.002
15. Chokephaibulkit K, Perng GC. Challenges for the formulation of a universal vaccine against dengue. Exp Biol Med (Maywood) (2013) 238(5):566-78. doi:10.1177/1535370212473703
16. Pier GB. Will there ever be a universal Staphylococcus aureus vaccine? Hum Vaccin Immunother (2013) 9(9):1865-76. doi:10.4161/hv.25182
17. Guan Q, Wang X, Wang X, Teng D, Mao R, Zhang Y, et al. Recombinant outer membrane protein A induces a protective immune response against Escherichia coli infection in mice. Appl Microbiol Biotechnol (2015) 99(13):5451-60. doi:10.1007/s00253-014-6339-6
18. Haake DA, Chao G, Zuerner RL, Barnett JK, Barnett D, Mazel M, et al. The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection. Infect Immun (2000) 68(4):2276-85. doi:10.1128/IAI.68.4.2276-2285.2000
19. Malmstrom J, Beck M, Schmidt A, Lange V, Deutsch EW, Aebersold R. Proteome-wide cellular protein concentrations of the human pathogen Leptospira interrogans. Nature (2009) 460(7256):762-5. doi:10.1038/nature08184
20. Cullen PA, Cordwell SJ, Bulach DM, Haake DA, Adler B. Global analysis of outer membrane proteins from Leptospira interrogans serovar Lai. Infect Immun (2002) 70(5):2311-8. doi:10.1128/IAI.70.5.2311-2318.2002
21. Pinne M, Haake DA. LipL32 is a subsurface lipoprotein of Leptospira interrogans: presentation of new data and reevaluation of previous studies. PLoS One (2013) 8(1):e51025. doi:10.1371/journal.pone.0051025
22. Murray GL, Srikram A, Hoke DE, Wunder EA Jr, Henry R, Lo M, et al. Major surface protein LipL32 is not required for either acute or chronic infection with Leptospira interrogans. Infect Immun (2009) 77(3):952-8. doi:10.1128/IAI.01370-08
23. Adler B, Lo M, Seemann T, Murray GL. Pathogenesis of leptospirosis: the influence of genomics. Vet Microbiol (2011) 153(1-2):73-81. doi:10.1016/j.vetmic.2011.02.055
24. Fisher RA. The Design of Experiments. Edinburgh: Oliver and Boyd Ltd (1935).
25. Dellagostin OA, Grassmann AA, Hartwig DD, Felix SR, da Silva EF, McBride AJ. Recombinant vaccines against leptospirosis. Hum Vaccin (2011) 7(11):1215-24. doi:10.4161/hv.7.11.17944
26. Matsunaga J, Barocchi MA, Croda J, Young TA, Sanchez Y, Siqueira I, et al. Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily. Mol Microbiol (2003) 49(4):929-45. doi:10.1046/j.1365-2958.2003.03619.x
27. Cerqueira GM, McBride AJ, Picardeau M, Ribeiro SG, Moreira AN, Morel V, et al. Distribution of the leptospiral immunoglobulin-like (Lig) genes in pathogenic Leptospira species and application of ligB to typing leptospiral isolates. J Med Microbiol (2009) 58(Pt 9):1173-81. doi:10.1099/jmm.0.009175-0
28. McBride AJ, Cerqueira GM, Suchard MA, Moreira AN, Zuerner RL, Reis MG, et al. Genetic diversity of the leptospiral immunoglobulin-like (Lig) genes in pathogenic Leptospira spp. Infect Genet Evol (2009) 9(2):196-205. doi:10.1016/j.meegid.2008.10.012
29. Fouts DE, Matthias MA, Adhikarla H, Adler B, Amorim-Santos L, Berg DE, et al. What makes a bacterial species pathogenic? Comparative genomic analysis of the genus Leptospira. PLoS Negl Trop Dis (2016) 10(2):e0004403. doi:10.1371/journal.pntd.0004403
30. Matsunaga J, Sanchez Y, Xu X, Haake DA. Osmolarity, a key environmental signal controlling expression of leptospiral proteins LigA and LigB and the extracellular release of LigA. Infect Immun (2005) 73(1):70-8. doi:10.1128/IAI.73.1.70-78.2005
31. Choy HA, Kelley MM, Chen TL, Moller AK, Matsunaga J, Haake DA. Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen. Infect Immun (2007) 75(5):2441-50. doi:10.1128/IAI.01635-06
32. Choy HA, Kelley MM, Croda J, Matsunaga J, Babbitt JT, Ko AI, et al. The multifunctional LigB adhesin binds homeostatic proteins with potential roles in cutaneous infection by pathogenic Leptospira interrogans. PLoS One (2011) 6(2):e16879. doi:10.1371/journal.pone.0016879
33. Hsieh CL, Chang E, Tseng A, Ptak C, Wu LC, Su CL, et al. Leptospira immunoglobulin-like protein B (LigB) binds to both the C-terminal 23 amino acids of fibrinogen alphaC domain and factor XIII: insight into the mechanism of LigB-mediated blockage of fibrinogen alpha chain cross-linking. PLoS Negl Trop Dis (2016) 10(9):e0004974. doi:10.1371/journal.pntd.0004974
34. Choy HA. Multiple activities of LigB potentiate virulence of Leptospira interrogans: inhibition of alternative and classical pathways of complement. PLoS One (2012) 7(7):e41566. doi:10.1371/journal.pone.0041566
35. Castiblanco-Valencia MM, Fraga TR, Pagotto AH, Serrano SM, Abreu PA, Barbosa AS, et al. Plasmin cleaves fibrinogen and the human complement proteins C3b and C5 in the presence of Leptospira interrogans proteins: a new role of LigA and LigB in invasion and complement immune evasion. Immunobiology (2016) 221(5):679-89. doi:10.1016/j.imbio.2016.01.001
36. Croda J, Figueira CP, Wunder EA Jr, Santos CS, Reis MG, Ko AI, et al. Targeted mutagenesis in pathogenic Leptospira species: disruption of the LigB gene does not affect virulence in animal models of leptospirosis. Infect Immun (2008) 76(12):5826-33. doi:10.1128/IAI.00989-08
37. Hartwig DD, Bacelo KL, Oliveira PD, Oliveira TL, Seixas FK, Amaral MG, et al. Mannosylated LigANI produced in Pichia pastoris protects hamsters against leptospirosis. Curr Microbiol (2014) 68(4):524-30. doi:10.1007/s00284-013-0505-4
38. Coutinho ML, Choy HA, Kelley MM, Matsunaga J, Babbitt JT, Lewis MS, et al. A LigA three-domain region protects hamsters from lethal infection by Leptospira interrogans. PLoS Negl Trop Dis (2011) 5(12):e1422. doi:10.1371/journal.pntd.0001422
39. Silva EF, Medeiros MA, McBride AJ, Matsunaga J, Esteves GS, Ramos JG, et al. The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine (2007) 25(33):6277-86. doi:10.1016/j.vaccine.2007.05.053
40. Palaniappan RU, McDonough SP, Divers TJ, Chen CS, Pan MJ, Matsumoto M, et al. Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection. Infect Immun (2006) 74(3):1745-50. doi:10.1128/IAI.74.3.1745-1750.2006
41. Koizumi N, Watanabe H. Leptospiral immunoglobulin-like proteins elicit protective immunity. Vaccine (2004) 22(11-12):1545-52. doi:10.1016/j.vaccine.2003.10.007
42. Faisal SM, Yan W, Chen CS, Palaniappan RU, McDonough SP, Chang YF. Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters. Vaccine (2008) 26(2):277-87. doi:10.1016/j.vaccine.2007.10.029
43. Faisal SM, Yan W, McDonough SP, Chang YF. Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity. Vaccine (2009) 27(3):378-87. doi:10.1016/j.vaccine.2008.10.089
44. Lourdault K, Wang LC, Vieira A, Matsunaga J, Melo R, Lewis MS, et al. Oral immunization with Escherichia coli expressing a lipidated form of LigA protects hamsters against challenge with Leptospira interrogans serovar Copenhageni. Infect Immun (2014) 82(2):893-902. doi:10.1128/IAI.01533-13
45. Oliveira TL, Bacelo KL, Schuch RA, Seixas FK, Collares T, Rodrigues OE, et al. Immune response in hamsters immunised with a recombinant fragment of LigA from Leptospira interrogans, associated with carrier molecules. Mem Inst Oswaldo Cruz (2016) 111(11):712-6. doi:10.1590/0074-02760160214
46. Lucas DS, Cullen PA, Lo M, Srikram A, Sermswan RW, Adler B. Recombinant LipL32 and LigA from Leptospira are unable to stimulate protective immunity against leptospirosis in the hamster model. Vaccine (2011) 29(18):3413-8. doi:10.1016/j.vaccine.2011.02.084
47. Yan W, Faisal SM, McDonough SP, Divers TJ, Barr SC, Chang CF, et al. Immunogenicity and protective efficacy of recombinant Leptospira immunoglobulin-like protein B (rLigB) in a hamster challenge model. Microbes Infect (2009) 11(2):230-7. doi:10.1016/j.micinf.2008.11.008
48. Forster KM, Hartwig DD, Seixas FK, Bacelo KL, Amaral M, Hartleben CP, et al. A conserved region of leptospiral immunoglobulin-like A and B proteins as a DNA vaccine elicits a prophylactic immune response against leptospirosis. Clin Vaccine Immunol (2013) 20(5):725-31. doi:10.1128/CVI.00601-12
49. Haake DA, Mazel MK, McCoy AM, Milward F, Chao G, Matsunaga J, et al. Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection. Infect Immun (1999) 67(12):6572-82.
50. Chang YF, Chen CS, Palaniappan RU, He H, McDonough SP, Barr SC, et al. Immunogenicity of the recombinant leptospiral putative outer membrane proteins as vaccine candidates. Vaccine (2007) 25(48):8190-7. doi:10.1016/j.vaccine.2007.09.020
51. Faisal SM, Yan W, McDonough SP, Chang CF, Pan MJ, Chang YF. Leptosome-entrapped leptospiral antigens conferred significant higher levels of protection than those entrapped with PC-liposomes in a hamster model. Vaccine (2009) 27(47):6537-45. doi:10.1016/j.vaccine.2009.08.051
52. Faisal SM, Yan W, McDonough SP, Mohammed HO, Divers TJ, Chang YF. Immune response and prophylactic efficacy of smegmosomes in a hamster model of leptospirosis. Vaccine (2009) 27(44):6129-36. doi:10.1016/j.vaccine.2009.08.029
53. Hartwig DD, Seixas FK, Cerqueira GM, McBride AJ, Dellagostin OA. Characterization of the immunogenic and antigenic potential of putative lipoproteins from Leptospira interrogans. Curr Microbiol (2011) 62(4):1337-41. doi:10.1007/s00284-010-9865-1
54. Hartwig DD, Forster KM, Oliveira TL, Amaral M, McBride AJ, Dellagostin OA. A prime-boost strategy using the novel vaccine candidate, LemA, protects hamsters against leptospirosis. Clin Vaccine Immunol (2013) 20(5):747-52. doi:10.1128/CVI.00034-13
55. Murray GL, Lo M, Bulach DM, Srikram A, Seemann T, Quinsey NS, et al. Evaluation of 238 antigens of Leptospira borgpetersenii serovar Hardjo for protection against kidney colonisation. Vaccine (2013) 31(3):495-9. doi:10.1016/j.vaccine.2012.11.028
56. Cullen PA, Xu X, Matsunaga J, Sanchez Y, Ko AI, Haake DA, et al. Surfaceome of Leptospira spp. Infect Immun (2005) 73(8):4853-63. doi:10.1128/IAI.73.8.4853-4863.2005
57. Haake DA, Matsunaga J. Characterization of the leptospiral outer membrane and description of three novel leptospiral membrane proteins. Infect Immun (2002) 70(9):4936-45. doi:10.1128/IAI.70.9.4936-4945.2002
58. Oliveira R, de Morais ZM, Goncales AP, Romero EC, Vasconcellos SA, Nascimento AL. Characterization of novel OmpA-like protein of Leptospira interrogans that binds extracellular matrix molecules and plasminogen. PLoS One (2011) 6(7):e21962. doi:10.1371/journal.pone.0021962
59. Fernandes CP, Seixas FK, Coutinho ML, Vasconcellos FA, Seyffert N, Croda J, et al. Monoclonal antibodies against LipL32, the major outer membrane protein of pathogenic Leptospira: production, characterization, and testing in diagnostic applications. Hybridoma (Larchmt) (2007) 26(1):35-41. doi:10.1089/hyb.2006.033
60. Seib KL, Zhao X, Rappuoli R. Developing vaccines in the era of genomics: a decade of reverse vaccinology. Clin Microbiol Infect (2012) 18(Suppl 5):109-16. doi:10.1111/j.1469-0691.2012.03939.x
61. Dellagostin OA, Grassmann AA, Rizzi C, Schuch RA, Jorge S, Oliveira TL, et al. Reverse vaccinology: an approach for identifying leptospiral vaccine candidates. Int J Mol Sci (2017) 18(1):158-73. doi:10.3390/ijms18010158
62. Fraga TR, Isaac L, Barbosa AS. Complement evasion by pathogenic Leptospira. Front Immunol (2016) 7:623. doi:10.3389/fimmu.2016.00623
63. Domingos RF, Fernandes LG, Romero EC, de Morais ZM, Vasconcellos SA, Nascimento AL. Novel Leptospira interrogans protein Lsa32 is expressed during infection and binds laminin and plasminogen. Microbiology (2015) 161(Pt 4):851-64. doi:10.1099/mic.0.000041
64. Evangelista KV, Hahn B, Wunder EA Jr, Ko AI, Haake DA, Coburn J. Identification of cell-binding adhesins of Leptospira interrogans. PLoS Negl Trop Dis (2014) 8(10):e3215. doi:10.1371/journal.pntd.0003215
65. Figueredo J, Siqueira G, Souza G, Heinemann M, Vasconcellos S, Chapola E, et al. Characterization of two new putative adhesins of Leptospira interrogans. Microbiology (2016) 163:37-51. doi:10.1099/mic.0.000411
66. Robbins GT, Hahn BL, Evangelista KV, Padmore L, Aranda PS, Coburn J. Evaluation of cell binding activities of Leptospira ECM adhesins. PLoS Negl Trop Dis (2015) 9(4):e0003712. doi:10.1371/journal.pntd.0003712
67. Silva LP, Fernandes LG, Vieira ML, de Souza GO, Heinemann MB, Vasconcellos SA, et al. Evaluation of two novel leptospiral proteins for their interaction with human host components. Pathog Dis (2016) 74(5):ftw040. doi:10.1093/femspd/ftw040
68. Pinne M, Haake DA. A comprehensive approach to identification of surface-exposed, outer membrane-spanning proteins of Leptospira interrogans. PLoS One (2009) 4(6):e6071. doi:10.1371/journal.pone.0006071
69. Wunder EA Jr, Figueira CP, Benaroudj N, Hu B, Tong BA, Trajtenberg F, et al. A novel flagellar sheath protein, FcpA, determines filament coiling, translational motility and virulence for the Leptospira spirochete. Mol Microbiol (2016) 101(3):457-70. doi:10.1111/mmi.13403
70. Rosario LA, Arencibia DF, Suarez YE, Infante JF, Valdes BY, Batista N. Cross-protection among unrelated Leptospira pathogens serovars: an unfinished story. Adv Clin Exp Med (2012) 21(5):581-9.
71. Klaasen HL, van der Veen M, Molkenboer MJ, Sutton D. A novel tetravalent Leptospira bacterin protects against infection and shedding following challenge in dogs. Vet Rec (2013) 172(7):181. doi:10.1136/vr.101100
72. Dib CC, Goncales AP, de Morais ZM, de Souza GO, Miraglia F, Abreu PA, et al. Cross-protection between experimental anti-leptospirosis bacterins. Braz J Microbiol (2014) 45(3):1083-8. doi:10.1590/S1517-83822014000300042
73. Sonrier C, Branger C, Michel V, Ruvoen-Clouet N, Ganiere JP, Andre-Fontaine G. Evidence of cross-protection within Leptospira interrogans in an experimental model. Vaccine (2000) 19(1):86-94. doi:10.1016/S0264-410X(00)00129-8
74. Srikram A, Zhang K, Bartpho T, Lo M, Hoke DE, Sermswan RW, et al. Cross-protective immunity against leptospirosis elicited by a live, attenuated lipopolysaccharide mutant. J Infect Dis (2011) 203(6):870-9. doi:10.1093/infdis/jiq127
75. Branger C, Sonrier C, Chatrenet B, Klonjkowski B, Ruvoen-Clouet N, Aubert A, et al. Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination. Infect Immun (2001) 69(11):6831-8. doi:10.1128/IAI.69.11.6831-6838.2001
76. Maneewatch S, Sakolvaree Y, Saengjaruk P, Srimanote P, Tapchaisri P, Tongtawe P, et al. Monoclonal antibodies to LipL32 protect against heterologous Leptospira spp. challenge. Hybridoma (Larchmt) (2008) 27(6):453-65. doi:10.1089/hyb.2008.0056
77. Forster KM, Hartwig DD, Oliveira TL, Bacelo KL, Schuch R, Amaral MG, et al. DNA prime-protein boost based vaccination with a conserved region of leptospiral immunoglobulin-like A and B proteins enhances protection against leptospirosis. Mem Inst Oswaldo Cruz (2015) 110(8):989-95. doi:10.1590/0074-02760150222
78. Varni V, Koval A, Nagel A, Ruybal P, Caimi K, Amadio AF. First genome sequence of Leptospira interrogans serovar Pomona, isolated from a bovine abortion. Genome Announc (2016) 4(3):e00345-16. doi:10.1128/genomeA.00345-16
79. Nally JE, Bayles DO, Hurley D, Fanning S, McMahon BJ, Arent Z. Complete genome sequence of Leptospira alstonii serovar Room22 strain GWTS #1. Genome Announc (2016) 4(6):e01230-16. doi:10.1128/genomeA.01230-16
80. Llanes A, Restrepo CM, Rajeev S. Whole genome sequencing allows better understanding of the evolutionary history of Leptospira interrogans serovar Hardjo. PLoS One (2016) 11(7):e0159387. doi:10.1371/journal.pone.0159387
81. Lehmann JS, Corey VC, Ricaldi JN, Vinetz JM, Winzeler EA, Matthias MA. Whole genome shotgun sequencing shows selection on Leptospira regulatory proteins during in vitro culture attenuation. Am J Trop Med Hyg (2016) 94(2):302-13. doi:10.4269/ajtmh.15-0401
82. Kremer FS, Eslabao MR, Jorge S, Oliveira NR, Labonde J, Santos MN, et al. Draft genome of the Leptospira interrogans strains, Acegua, RCA, Prea, and Capivara, obtained from wildlife maintenance hosts and infected domestic animals. Mem Inst Oswaldo Cruz (2016) 111(4):280-3. doi:10.1590/0074-02760160010
83. Kremer FS, Eslabao MR, Provisor M, Woloski RD, Ramires OV, Moreno LZ, et al. Draft genome sequences of Leptospira santarosai strains U160, U164, and U233, isolated from asymptomatic cattle. Genome Announc (2015) 3(4):e00910-15. doi:10.1128/genomeA.00910-15
84. Monaris D, Sbrogio-Almeida ME, Dib CC, Canhamero TA, Souza GO, Vasconcellos SA, et al. Protective immunity and reduced renal colonization induced by vaccines containing recombinant Leptospira interrogans outer membrane proteins and flagellin adjuvant. Clin Vaccine Immunol (2015) 22(8):965-73. doi:10.1128/CVI.00285-15
85. Bacelo KL, Hartwig DD, Seixas FK, Schuch R, Moreira Ada S, Amaral M, et al. Xanthan gum as an adjuvant in a subunit vaccine preparation against leptospirosis. Biomed Res Int (2014) 2014:636491. doi:10.1155/2014/636491
86. Guy B. The perfect mix: recent progress in adjuvant research. Nat Rev Microbiol (2007) 5(7):505-17. doi:10.1038/nrmicro1681
87. Azmi F, Ahmad Fuaad AA, Skwarczynski M, Toth I. Recent progress in adjuvant discovery for peptide-based subunit vaccines. Hum Vaccin Immunother (2014) 10(3):778-96. doi:10.4161/hv.27332
88. Stassijns J, Bollaerts K, Baay M, Verstraeten T. A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among children. Vaccine (2016) 34(6):714-22. doi:10.1016/j.vaccine.2015.12.024
89. Liang F, Lore K. Local innate immune responses in the vaccine adjuvant-injected muscle. Clin Transl Immunology (2016) 5(4):e74. doi:10.1038/cti.2016.19
90. Zuerner RL. Host response to Leptospira infection. Curr Top Microbiol Immunol (2015) 387:223-50. doi:10.1007/978-3-662-45059-8_9
91. Pizza M, Scarlato V, Masignani V, Giuliani MM, Arico B, Comanducci M, et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science (2000) 287(5459):1816-20. doi:10.1126/science.287.5459.1816
92. Etz H, Minh DB, Henics T, Dryla A, Winkler B, Triska C, et al. Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proc Natl Acad Sci U S A (2002) 99(10):6573-8. doi:10.1073/pnas.092569199
93. Freudenstein H, Hein B. Potency of leptospiral vaccines and protection against chronic infection in golden hamsters. Comp Immunol Microbiol Infect Dis (1991) 14(3):229-34. doi:10.1016/0147-9571(91)90003-V
94. Srinivas GB, Walker A, Rippke B. USDA regulatory guidelines and practices for veterinary Leptospira vaccine potency testing. Biologicals (2013) 41(5):298-302. doi:10.1016/j.biologicals.2013.06.005
95. Zuerner RL, Alt DP, Palmer MV. Development of chronic and acute golden Syrian hamster infection models with Leptospira borgpetersenii serovar Hardjo. Vet Pathol (2012) 49(2):403-11. doi:10.1177/0300985811409252
96. Gomes-Solecki M, Santecchia I, Werts C. Animal models of leptospirosis: of mice and hamsters. Front Immunol (2017) 8(58). doi:10.3389/fimmu.2017.00058
97. Santos CS, Macedo JO, Bandeira M, Chagas-Junior AD, McBride AJ, McBride FW, et al. Different outcomes of experimental leptospiral infection in mouse strains with distinct genotypes. J Med Microbiol (2010) 59(Pt 9):1101-6. doi:10.1099/jmm.0.021089-0
98. Bandeira M, Santos CS, de Azevedo EC, Soares LM, Macedo JO, Marchi S, et al. Attenuated nephritis in inducible nitric oxide synthase knockout C57BL/6 mice and pulmonary hemorrhage in CB17 SCID and recombination activating gene 1 knockout C57BL/6 mice infected with Leptospira interrogans. Infect Immun (2011) 79(7):2936-40. doi:10.1128/IAI.05099-11
99. Athanazio DA, Silva EF, Santos CS, Rocha GM, Vannier-Santos MA, McBride AJ, et al. Rattus norvegicus as a model for persistent renal colonization by pathogenic Leptospira interrogans. Acta Trop (2008) 105(2):176-80. doi:10.1016/j.actatropica.2007.10.012